Keith A A Fox - JoVE Visualize

Showing results (121-130 of 433) with videos related to

Pageof 44

Sort By:

The American Journal of Medicine|January 9, 2007

Use of heparins in Non-ST-elevation acute coronary syndromesJoel M Gore, Frederick A Spencer, Robert J Goldberg, et al.

The Canadian Journal of Cardiology|April 11, 2016

A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk ScoreShamir R Mehta, John W Eikelboom, Purnima Rao-Melacini, et al.

Circulation|December 27, 2011

Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR)Peter Damman, Lars Wallentin, Keith A A Fox, et al.

American Heart Journal|December 13, 2005

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.

Circulation. Cardiovascular Quality and Outcomes|March 22, 2017

Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency CasesDarragh O'Neill, Owen Nicholas, Chris P Gale, et al.

Journal of the American College of Cardiology|June 15, 2007

The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trialKeith A A Fox, Elliott M Antman, Gilles Montalescot, et al.

Clinical Cardiology|April 18, 2018

Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registryBrian J Potter, Giuseppe Andò, Giovanni Cimmino, et al.

European Heart Journal. Acute Cardiovascular Care|March 6, 2021

The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registriesFrançois Schiele, Chris P Gale, Tabassome Simon, et al.

American Heart Journal|June 25, 2004

Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled studyGraham S Hillis, Claire V Pearson, Scott A Harding, et al.

Stroke|July 3, 2010

Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trialGraeme J Hankey, Werner Hacke, J Donald Easton, et al.

Pageof 44

Showing results (121-130 of 433) with videos related to

Sort By:

Pageof 44

The American Journal of Medicine|January 9, 2007

Use of heparins in Non-ST-elevation acute coronary syndromesJoel M Gore, Frederick A Spencer, Robert J Goldberg, et al.

The Canadian Journal of Cardiology|April 11, 2016

A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk ScoreShamir R Mehta, John W Eikelboom, Purnima Rao-Melacini, et al.

Circulation|December 27, 2011

Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR)Peter Damman, Lars Wallentin, Keith A A Fox, et al.

American Heart Journal|December 13, 2005

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes, Shamir R Mehta, Salim Yusuf, et al.

Circulation. Cardiovascular Quality and Outcomes|March 22, 2017

Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency CasesDarragh O'Neill, Owen Nicholas, Chris P Gale, et al.

Journal of the American College of Cardiology|June 15, 2007

The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trialKeith A A Fox, Elliott M Antman, Gilles Montalescot, et al.

Clinical Cardiology|April 18, 2018

Time trends in antithrombotic management of patients with atrial fibrillation treated with coronary stents: Results from TALENT-AF (The internAtionaL stENT - Atrial Fibrillation study) multicenter registryBrian J Potter, Giuseppe Andò, Giovanni Cimmino, et al.

European Heart Journal. Acute Cardiovascular Care|March 6, 2021

The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registriesFrançois Schiele, Chris P Gale, Tabassome Simon, et al.

American Heart Journal|June 25, 2004

Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled studyGraham S Hillis, Claire V Pearson, Scott A Harding, et al.

Stroke|July 3, 2010

Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trialGraeme J Hankey, Werner Hacke, J Donald Easton, et al.

Pageof 44